Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2026-01-29 @ 9:54 AM
Study NCT ID:
NCT02433795
Status:
COMPLETED
Last Update Posted:
2021-09-24
First Post:
2015-04-05
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine Plus Rituximab (BR) for Relapsed or Progressive Marginal Zone B-cell Lymphoma (MZBCL)
Sponsor:
Organization: